Siga Technologies (SIGA) Cash from Investing Activities (QoQ) (2010 - 2025)
Siga Technologies (SIGA) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -28,957,500.00% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | -39.55% |
| Dec 31, 2024 | 20.46% |
| Sep 30, 2024 | -926.41% |
| Jun 30, 2021 | 22.03% |
| Mar 31, 2020 | -774,950.00% |
| Dec 31, 2019 | 99.99% |
| Sep 30, 2019 | -671,566.67% |
| Jun 30, 2019 | 100.03% |
| Mar 31, 2019 | -100.01% |
| Dec 31, 2017 | -207.60% |
| Sep 30, 2017 | 62.07% |
| Dec 31, 2016 | 119,966,000.00% |
| Sep 30, 2016 | 100.04% |
| Jun 30, 2016 | 70.23% |
| Mar 31, 2016 | 81.49% |
| Dec 31, 2015 | 27.51% |
| Mar 31, 2015 | 185,973.61% |
| Dec 31, 2014 | 99.95% |